Amos Chery, Director of Pharmacy Operations and Regulatory Compliance, MedStar Health | Life Sciences Review

Navigating the Future of Pharmacy

Amos Chery, Director of Pharmacy Operations and Regulatory Compliance, MedStar Health
Ramin Daron, VP, Data Architecture and Technology, R&D Data Science Institute, Takeda | Life Sciences Review

Building a Data Factory for Speed and Innovation in Life Sciences

Ramin Daron, VP, Data Architecture and Technology, R&D Data Science Institute, Takeda
Saleh Yusuf, Director, North America Logistics, Kedrion Biopharma | Life Sciences Review

Acceptance of Variability and Change in Supply Chain

Saleh Yusuf, Director, North America Logistics, Kedrion Biopharma
Robert L. Moore, Tianyu Pharm | Life Sciences Review  | Chronic Disease and Anti Cancer Drugs Supplier of the Year

Tianyu Pharm: Engineering Reliability from Molecule to Market

Robert L. Moore, Ph.D., Senior Director of Business Development for North America
Tatiana Sorokina, Solutions Director, Data Science & Artificial Intelligence, DSAI Innovation Execution, Novartis | Life Sciences Review

Put your Frontline Teams in the Driving Seat through a Personalized, Customer-Centric Approach

Tatiana Sorokina, Solutions Director, Data Science & Artificial Intelligence, DSAI Innovation Execution, Novartis
Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc. | Life Sciences Review

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Paul R. WhitacrePMP, Associate Director, Digital Excellence, Commercial Strategy & OperationsAstellas Pharma US, Inc
Ulf Staginnus, VP international Market Access & Pricing, Blueprint Medicines Sunjeet Sawhney, Chief Executive Officer, Rappta-Therapeutics | Life Sciences Review

Is It Time to Add Access to the C-Suite?

Sunjeet SawhneyChief Executive Officer, Rappta-TherapeuticsLondon
Dan O’Connor, VP Drug Discovery, Western Markets at Molecular Devices | Life Sciences Review

A New Paradigm in the Synthetic Biology Space

Dan O’Connor, VP Drug Discovery, Western Markets at Molecular Devices
A panel moderated by Kelly H. Zou, Head, Global Medical Analytics and Real-World Evidence, Viatris; Founder, AI4Purpose | Life Sciences Review

Health Tech and Artificial Intelligence in Life Sciences

A panel moderated by Kelly H. Zou, Head, Global Medical Analytics and Real-World Evidence, Viatris; Founder, AI4Purpose
Robert J. Prill, Director of Data Science and AI, Ferring Pharmaceuticals And Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Pharmaceuticals | Life Sciences Review

Challenges and Opportunities for AI in Drug Discovery

Robert J. Prill, Director of Data Science and AI, Ferring Pharmaceuticals
Shantel Rodriguez, RN, BSN, Chief Nursing Officer, MB Healthcare | Life Sciences Review

Inappropriate Antibiotic Prescribing in Long-Term Care Facilities: A Growing Concern

Shantel Rodriguez, RN, BSN, Chief Nursing Officer, MB Healthcare
Claudia Casalino, Corporate Compliance Manager at Alfasigma | Life Sciences Review

Insights into the Emerging Trends in Life Sciences

Claudia Casalino, Corporate Compliance Manager at Alfasigma
Ryan Garland, MHA BS RT(R), AVP- South Region Radiology & Respiratory, Endeavor Health | Life Sciences Review

Challenges, Trends, and Strategies in Modern Healthcare - Light Therapy

Ryan Garland, MHA BS RT(R), AVP- South Region Radiology & Respiratory, Endeavor Health
Dr. Alexander Rotenberg, Galibra Neuroscience | Life Sciences Review  | Top GABA Disorders Treatment

Galibra Neuroscience: Restoring Balance to the Brain’s Most Fragile Chemistry

Dr. Alexander Rotenberg, Co-Founder and Dr. Henry Lee, Co-Founder